BioMerieux (LTS:0RUG) Ending Cash Position : €442 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is BioMerieux Ending Cash Position?

BioMerieux's Ending Cash Position for the quarter that ended in Dec. 2024 was €442 Mil.

BioMerieux's quarterly Ending Cash Position declined from Dec. 2023 (€333 Mil) to Jun. 2024 (€252 Mil) but then increased from Jun. 2024 (€252 Mil) to Dec. 2024 (€442 Mil).

BioMerieux's annual Ending Cash Position declined from Dec. 2022 (€529 Mil) to Dec. 2023 (€333 Mil) but then increased from Dec. 2023 (€333 Mil) to Dec. 2024 (€442 Mil).

BioMerieux Ending Cash Position Historical Data

The historical data trend for BioMerieux's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Ending Cash Position Chart

BioMerieux Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

371.30

787.30

528.70

333.40

442.10

BioMerieux Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															528.70	400.70	333.40	252.40	442.10

BioMerieux Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BioMerieux's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	333.3	+	108.8
	=	442

BioMerieux's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	252.4	+	189.7
	=	442

BioMerieux Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BioMerieux's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BioMerieux Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (LTS:0RUG) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

BMXMF:USA BIMp:UK BIM:France EYWN:Germany

Address

Marcy l’Etoile, Lyon, FRA, 69280

Website

http://www.biomerieux.com

BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (34% of 2023 sales), microbiology (39%), immunoassays (10%), and industrial applications (about 17%). The Amercas account for the largest portion of the firm's revenue (45%), followed by Europe, the Middle East, and Africa (31%), and Asia-Pacific (16%). BioMérieux is headquartered in Marcy-l'Etoile, France.

BioMerieux Headlines

No Headlines